Navigation Links
Women under-represented in cancer research, U-M study finds
Date:6/8/2009

ANN ARBOR, Mich. Women are under-represented in clinical cancer research published in high-impact journals, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center.

Taking into account the incidence of particular types of cancer among women, studies included a smaller proportion of women than should be expected. The analysis looked specifically at studies of cancer types that were not gender specific, including colon cancer, oral cancers, lung cancer, brain tumors and lymphomas.

The authors looked at 661 prospective clinical studies with more than 1 million total participants. Results of this study appear online in the journal Cancer and will be published in the July 15 print issue.

"In the vast majority of individual studies we analyzed, fewer women were enrolled than we would expect given the proportion of women diagnosed with the type of cancer being studied. We're seeing it across the board in all cancer types," says study author Reshma Jagsi, M.D., D.Phil., assistant professor of radiation oncology at the U-M Medical School.

"It's so important that women are appropriately represented in research. We know there are biological differences between the sexes, as well as social and cultural differences. Studies need to be able to assess whether there are differences in responses to treatment, for example, between women and men," she adds.

The National Institutes of Health's Revitalization Act of 1993 explicitly calls out the importance of including women in clinical research, noting that clinical trials should enroll adequate numbers of women to allow for subgroup analysis.

The U-M researchers found that studies reporting government funding did include higher numbers of women participants, but the impact was modest 41 percent, compared to 37 percent for studies not receiving government funding.

Traditionally, researchers were told not to include people of vulnerable populations in their studies. This group included women of childbearing age. "By protecting them from research, we're excluding them," Jagsi notes.

Previous studies have found some barriers to clinical trial participation are lack of information, fear and a perception of interfering with personal responsibilities, such as child care.

"Sometimes participating in research studies can be time intensive. Women today are often stretched very thin trying to deal with the balance between domestic responsibilities, their cancer diagnosis, and often a career as well. They may be particularly likely to find clinical trials too burdensome. In that case, researchers should consider providing compensation to help with transportation or child care expenses," Jagsi says.

This under-representation of women is not necessarily the result of conscious decisions, points out senior author Peter Ubel, M.D., director of the Center for Behavioral and Decision Sciences in Medicine at U-M.

"Clinical researchers are not purposely trying to exclude women from their studies. All the more reason they need to consciously and earnestly revise their recruitment methods to give more women a chance to volunteer," Ubel says.


'/>"/>

Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert

Related medicine news :

1. Women under-represented in most cancer research
2. Middle-aged women experience more stress but have lower blood pressure
3. Grilled Meats Not Tied to Breast Cancer in Older Women
4. MassMutual Survey: Female Cancer Survivors Better Prepared Financially Than Other Women For Lifes Unexpected Events
5. One Woman Initiative Announces First Grants to Womens Organizations in Five Nations
6. Women may not be so picky after all about choosing a mate
7. Study: Benefit to women not enough to sway men to get HPV vaccine
8. Experts reach consensus on diagnosis and treatment of bleeding disorders in women
9. AARP to Support the Love/Avon Army of Women
10. Garden of Life Partners with WomenHeart to Help Combat Womens Heart Disease
11. Go Red For Women(R) Launches 12-Week Program to Improve Heart Health and Save Lives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... The Santana Telehealth Project was honored with ... — the American Telemedicine Association’s annual conference, on April 23 in Orlando, FL. , ... to improve the lives of the poor and underserved in other parts of the ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... Research Association’s Outstanding Public Communication of Education Research Award. The award honors scholars ... education communities. It recognizes a scholar who has demonstrated the capacity to deepen ...
(Date:4/24/2017)... Calif. (PRWEB) , ... April 24, 2017 , ... The ... $1.6 million in charitable dental services to 1,961 people during the April 22-23 event ... at no charge to Californians who experience barriers to care, CDA Cares educates the ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... The John ... innovative technology that allows anyone, anywhere to track their cognitive health, and share results ... check their own brain health on the museum's website. , BrainCheck founder, Dr. David ...
(Date:4/24/2017)... ... April 24, 2017 , ... My T Chai, a South ... are now available for purchase on RevNutrition.com, a popular website specializing in sales of ... and popularized in ancient India and Siam. It spread across Asia and Africa quickly, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 Cardiology ... during the projected period The Cardiology Devices segment ... more than US$ 15 Mn in 2018 over 2017. By ... reach a market valuation close to US$ 700 Mn, expanding ... Cardiology Devices segment dominated the Asia Pacific ...
Breaking Medicine Technology: